Molecular Data Valuation

MKDTYDelisted Stock  USD 0.01  0.01  2,567%   
Molecular Data seems to be overvalued based on Macroaxis valuation methodology. Macroaxis essentially forecasts value of Molecular Data from analyzing the firm technical indicators and probability of bankruptcy. Most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
0.01
Please note that Molecular Data's price fluctuation is very steady at this time. Calculation of the real value of Molecular Data is based on 3 months time horizon. Increasing Molecular Data's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Molecular Data is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Molecular Pink Sheet. However, Molecular Data's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.008 Real  0.005568 Hype  0.01
The intrinsic value of Molecular Data's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Molecular Data's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.01
Real Value
0.01
Upside
Estimating the potential upside or downside of Molecular Data helps investors to forecast how Molecular pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Molecular Data more accurately as focusing exclusively on Molecular Data's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details

Molecular Data Total Value Analysis

Molecular Data is now anticipated to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Molecular Data fundamentals before making investing decisions based on enterprise value of the company

Molecular Data Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Molecular suggests not a very effective usage of assets in November.

About Molecular Data Valuation

Our relative valuation model uses a comparative analysis of Molecular Data. We calculate exposure to Molecular Data's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Molecular Data's related companies.

8 Steps to conduct Molecular Data's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Molecular Data's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Molecular Data's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Molecular Data's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Molecular Data's revenue streams: Identify Molecular Data's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Molecular Data's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Molecular Data's growth potential: Evaluate Molecular Data's management, business model, and growth potential.
  • Determine Molecular Data's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Molecular Data's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in Molecular Pink Sheet

If you are still planning to invest in Molecular Data check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molecular Data's history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity